English
Back
Open Account
牛牛名人追蹤
wrote a column · Apr 29 14:22 ·

Tracking Cathie Wood: Aggressively scooped up nearly 600,000 shares of gene-editing star NTLA, increased investment in AI computing power, decisively reduced streaming media assets

On Tuesday (April 28), the three major US stock indices all weakened. Entering the final week of April, the market is facing a crucial 'tech giant earnings season.' Amid rumors that OpenAI failed to meet internal targets, investors are reassessing the ability of massive AI investments to generate returns. Sell-offs in tech giants dragged down the broader market as traders weigh AI profit expectations against macroeconomic data.
In this market situation, Cathie Wood made a significant purchase of nearly 600,000 shares in NTLA, a leader in gene editing, and also increased her holdings in the AI infrastructure sector. $Alphabet-C (GOOG.US)$$CoreWeave (CRWV.US)$ ; decisively reduced positions in consumer streaming platforms that have peaked in growth $Roku Inc (ROKU.US)$$Spotify Technology (SPOT.US)$ and some financial assets.
On Tuesday (April 28), the three major US stock indices all weakened. Entering the final week of April, the market is facing a crucial 'tech giant earnings season.' Amid rumors that OpenAI failed to meet internal targets, investors are reassessing the ability of massive AI investments to generate returns. Sell-offs in tech giants dragged down the broader market as traders weigh AI profit expectations against macroeconomic data. In this market situation, Cathie Wood made a significant purchase of nearly 600,000 shares in NTLA, a leader in gene editing, and also increased her holdings in the AI infrastructure sector. $Alphabet-C (GOOG.US)$ 、 $CoreWeave (CRWV.US)$ ; on the sell side, she decisively reduced positions in consumer streaming platforms where growth has peaked $Roku Inc (ROKU.US)$ 、 $Spotify Technology (SPOT.US)$ and some financial assets. Buying Strategy: Betting on gene repair potential, positioning in foundational AI infrastructure. Heavily buying Intellia Therapeutics$Intellia Therapeutics (NTLA.US)$596,200 shares:This is a rare large-scale buy by ARK in the biotech sector recently. Intellia focuses on CRISPR-based in vivo gene-editing technology. ARK purchased 260,000 shares on April 27 and doubled its position on April 28. Continuous accumulation reflects...
Buying direction: Betting on gene-editing potential, positioning in AI infrastructure
Heavily bought Intellia Therapeutics$Intellia Therapeutics (NTLA.US)$596,200 shares:This is a rare large-scale purchase by ARK in the biotech sector recently. Intellia specializes in CRISPR in vivo gene editing technology. ARK purchased 260,000 shares on April 27 and doubled its position on the 28th. The consecutive builds reflect ARK's high expectations for NTLA’s upcoming clinical data or commercial progress, with funds clearly flowing into assets with breakthrough foundational technologies.
Increased stake in AI cloud unicorn CoreWeave$CoreWeave (CRWV.US)$162,300 shares and Alphabet $Alphabet-C (GOOG.US)$40,700 shares:ARK had previously reduced its position in CRWV at an elevated level in mid-April but has now re-entered at a lower price, reflecting its long-term view of a supply-demand imbalance in the AI GPU rental market. As for Alphabet, it is reported that the U.S. Department of Defense is expanding its adoption of its Gemini AI model, which not only confirms its technical prowess but also boosts market confidence in its B2B business. ARK's position building this time aims to bet on AI-powered cloud computing (Google Cloud) and core search advertising capabilities delivering strong monetization potential.
Adding to Kratos Defense position$Kratos Defense & Security Solutions (KTOS.US)$98,400 shares:Under the normalization of geopolitical friction, KTOS continues to secure orders with its low-cost tactical drone advantage. This is one of the few targets in the ARK portfolio that possesses both defense and safe-haven attributes.
Sell direction: Exiting consumer streaming platforms to optimize financial asset allocation
Cathie Wood is withdrawing funds from the highly competitive ToC application sector to support investments in cutting-edge technology.
Reducing Roku streaming media hardware and platform position $Roku Inc (ROKU.US)$37,100 shares and Spotify ($Spotify Technology (SPOT.US)$11,500 shares):Roku faces competition from giants like Amazon and Alphabet in the smart TV operating system space, putting pressure on advertising revenue growth. Although Spotify's recent earnings performance has been solid, rising AI-related costs and strategic risks have led several major banks to downgrade its target price.
Reducing Bullish cryptocurrency exchange position $Bullish (BLSH.US)$27,500 shares and Intercontinental Exchange $Intercontinental Exchange (ICE.US)$10,800 shares:Against the backdrop of volatility in the cryptocurrency market and the lack of explosive expectations in traditional exchanges, this move represents a routine asset reallocation aimed at shifting liquidity to sectors with more breakout potential.
Summarizing recent portfolio adjustment trends, 'Wood姐' is clearly increasing the strategic weight of 'AI infrastructure' and 'gene editing.' Based on the current earnings season performance, fellow investors, how do you view the investment value of AI underlying computing power (e.g., GOOG, CRWV) in the second quarter?
Futubull [Opportunities page] Now featuring the ability to track portfolios of renowned investors! Choose from multiple celebrity holdings, follow the investment strategies of top players with one click, accurately target high-quality stocks, and invest with greater confidence!
On Tuesday (April 28), the three major US stock indices all weakened. Entering the final week of April, the market is facing a crucial 'tech giant earnings season.' Amid rumors that OpenAI failed to meet internal targets, investors are reassessing the ability of massive AI investments to generate returns. Sell-offs in tech giants dragged down the broader market as traders weigh AI profit expectations against macroeconomic data. In this market situation, Cathie Wood made a significant purchase of nearly 600,000 shares in NTLA, a leader in gene editing, and also increased her holdings in the AI infrastructure sector. $Alphabet-C (GOOG.US)$ 、 $CoreWeave (CRWV.US)$ ; on the sell side, she decisively reduced positions in consumer streaming platforms where growth has peaked $Roku Inc (ROKU.US)$ 、 $Spotify Technology (SPOT.US)$ and some financial assets. Buying Strategy: Betting on gene repair potential, positioning in foundational AI infrastructure. Heavily buying Intellia Therapeutics$Intellia Therapeutics (NTLA.US)$596,200 shares:This is a rare large-scale buy by ARK in the biotech sector recently. Intellia focuses on CRISPR-based in vivo gene-editing technology. ARK purchased 260,000 shares on April 27 and doubled its position on April 28. Continuous accumulation reflects...
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Thumbs Up
6
Emm
1
103K Views
Report
Comments (6)
Write a Comment...
6
7
15